Rethinking the “Pre” in Pre-Therapy Counseling: No Benefit of Additional Visits Prior to Therapy on Adherence or Viremia in Ugandans Initiating ARVs
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Many guidelines recommend adherence counseling prior to initiating antiretrovirals (ARVs), however the additional benefit of pre-therapy counseling visits on early adherence is not known. We sought to assess for a benefit of adherence counseling visits prior to ARV initiation versus adherence counseling during the early treatment period. METHODS: We performed a secondary analysis of data from a prospective cohort of HIV-infected patients in Mbarara, Uganda. Adults were enrolled upon initiation of ARVs. Our primary exposure of interest was ARV adherence counseling prior to initiating therapy (versus concurrent with initiation of therapy). Our outcomes of interest were: 1) average adherence >90% in first three months; 2) absence of treatment interruptions >72 hours in first three months; and 3) Viral load >400 copies/ml at the three month visit. We fit univariable and multivariable regression models, adjusted for predictors of ARV adherence, to estimate the association between additional pre-therapy counseling visits and our outcomes. RESULTS: 300 participants had records of counseling, of whom 231 (77%) completed visits prior to initiation of ARVs and 69 (23%) on or shortly after initiation. Median age was 33, 71% were female, and median CD4 was 133 cell/ml. Median 90-day adherence was 95%. Participants who completed pre-therapy counseling visits had longer delays from ARV eligibility to initiation (median 49 vs 14 days, p<0.01). In multivariable analyses, completing adherence counseling prior to ARV initiation was not associated with average adherence >90% (AOR 0.8, 95%CI 0.4-1.5), absence of treatment gaps (AOR 0.7, 95%CI 0.2-1.9), or HIV viremia (AOR 1.1, 95%CI 0.4-3.1). CONCLUSIONS: Completion of adherence counseling visits prior to ARV therapy was not associated with higher adherence in this cohort of HIV-infected patients in Uganda. Because mortality and loss-to-follow-up remain high in the pre-ARV period, policy makers should reconsider whether counseling can be delivered with ARV initiation, especially in patients with advanced disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hopkins Symptom Checklist (HSCL): A self-report symptom inventory
Derogatis, L. R., Lipman, R. S., Rickels, K., Uhlenhuth, E. H., & Covi, L. (1974) · Behavioral Science · doi:10.1002/bs.3830190102 · Cited by 4,604 · cited 2×
“75 on the Hopkins Symptoms Score Checklist [22], and alcohol use with the AUDIT-C screen [23] in the multivariable model.”
MethodInfluentialMills, E. J., Nachega, J. B., Bangsberg, D. R., Singh, S., Rachlis, B., Wu, P., Wilson, K., Buchan, I., Gill, C. J., & Cooper, C. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030438 · Cited by 818
Self-citationChung, M. H., Richardson, B. A., Tapia, K., Benki-Nugent, S., Kiarie, J. N., Simoni, J. M., Overbaugh, J., Attwa, M., & John-Stewart, G. C. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1000422 · Cited by 109 · cited 1×
“[36].”
Cited by
Rosen, S., Maskew, M., Fox, M. P., Nyoni, C., Mongwenyana, C., Malete, G., Sanne, I., Bokaba, D., Sauls, C., Rohr, J., et al. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002015 · Cited by 326
Koenig, S. P., Dorvil, N., Dévieux, J. G., Hedt-Gauthier, B. L., Riviere, C., Faustin, M., Lavoile, K., Perodin, C., Apollon, A., Duverger, L., et al. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002357 · Cited by 287
Lankowski, A. J., Siedner, M. J., Bangsberg, D. R., & Tsai, A. C. (2014) · AIDS and Behavior · doi:10.1007/s10461-014-0729-8 · Cited by 260
Self-citationUrinary cell-free DNA is a versatile analyte for monitoring infections of the urinary tract
Burnham, P., Dadhania, D., Heyang, M., Chen, F., Westblade, L. F., Suthanthiran, M., Lee, J. R., & De Vlaminck, I. (2018) · Nature Communications · doi:10.1038/s41467-018-04745-0 · Cited by 160
Amanyire, G., Semitala, F. C., Namusobya, J., Katuramu, R., Kampiire, L., Wallenta, J., Charlebois, E., Camlin, C., Kahn, J., Chang, W., et al. (2016) · The Lancet HIV · doi:10.1016/s2352-3018(16)30090-x · Cited by 141
Self-citationDryden-Peterson, S., Bennett, K., Hughes, M. D., Veres, A., John, O., Pradhananga, R., Boyer, M., Brown, C., Sakyi, B., van Widenfelt, E., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0117181 · Cited by 37
“These include point-of-care CD4 testing [40], decentralization of services to minimize transportation barriers [41,42], and minimizing or removing repeated adherence counseling visits [32].”
BackgroundMethodSelf-citation
Metadata
- Authors
- Siedner, M. J., Lankowski, A., Haberer, J. E., Kembabazi, A., Emenyonu, N., Tsai, A. C., Muzoora, C., Geng, E., Martin, J. N., & Bangsberg, D. R.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-06-26
- Volume
- 7
- Issue
- 6
- Pages
- e39894
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2144686010
- Cited by
- 86
- References
- 3
- FWCI
- 6.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.